MAORI: Mobility, Functional Autonomy and Respiratory Function After Prolonged Stay in Intensive Care Unit

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04319822
Collaborator
(none)
120
1
30

Study Details

Study Description

Brief Summary

The hospital survival of patients hospitalized after prolonged stay in intensive care unit has improved however there are a loss of functional autonomy and an impaired of peripheral and respiratory muscle performance, what leads to an impairment life's quality. These sequels constitute the Post Intensive Care Syndrome (PICS).

The objective of this cohort is to describe the functional autonomy at 6 months of a prolonged stay in intensive care unit and to study the associations between functional autonomy and 1 / the biological data obtained from quadriceps biopsies / the trajectory of post-resuscitation care.

The primary endpoint is functional autonomy at 6 months of ICU stay, assessed by the Functional Independence Measure (FIM) score.

In order to take into account a rate of loss of sight we propose to include in this cohort 120 subjects during their stay in intensive care unit.

Condition or Disease Intervention/Treatment Phase
  • Other: blood sample and muscular biopsy
N/A

Detailed Description

The hospital survival of patients hospitalized after prolonged stay in intensive care unit has improved however there are a loss of functional autonomy and an impaired of peripheral and respiratory muscle performance, what leads to an impairment life's quality. These sequels constitute the Post Intensive Care Syndrome (PICS). Incomplete understanding of the physiopathological mechanisms that allow the recovery of functional autonomy and the lack of consideration of post-intensive care pathway seems central to explain the contrasting results of therapeutic trials in this syndrome.

Incomplete understanding of the physiopathological mechanisms that allow the recovery of functional autonomy and the lack of consideration of post-intensive care pathway seems relevant to explain the contrasting results of therapeutic trials in this syndrome.

The objective of this cohort is to describe the functional autonomy at 6 months of a prolonged stay in intensive care unit and to study the associations between functional autonomy and 1 / the biological data obtained from quadriceps biopsies / the trajectory of post-resuscitation care

Patient at high risk of loss on functional autonomy, staying in the three intensive unit care participants will be recruited, if they present inclusion criteria and don't present exclusion criteria Inclusion criteria: - mechanical ventilation for at least 72 hours and extra-respiratory organ failure Exclusion criteria : neurological or psychiatric deficit preventing the performance of assessment tests, chronic ventilation on tracheotomy, bedridden patient or moribund

The primary endpoint is functional autonomy at 6 months of ICU stay, assessed by the Functional Independence Measure (FIM) score. The secondary endpoints are survival, peripheral and respiratory muscle performance, metabolic stress testing, biologic features associated with muscle regeneration (quadriceps biopsy in resuscitation (before and after) and one at M6) , the quality of life and the path of care post-resuscitation. The statistical analysis will make it possible to describe the population according to 3 groups of the same size according to the Tertiles of the FIM to M6. The analysis will look for variables associated with belonging to the "case" group: patients with the highest disability (last testeile of the FIM score) compared to "controls": patients with a less severe disability (first two tiertiles of the score) FIM). In order to take into account a rate of loss of sight we propose to include in this cohort 120 subjects during their stay in intensive care unit.

Progress: 2 visits are planned (ICU, M6 and monthly telephone interviews). The duration of the inclusions will be 30 months and the duration of the follow-up of the patients will be 6 months.

Prospect :
  • identification of physiopathological and structural factors (post-ICU trajectory) associated with recovery of functional autonomy and respiratory and peripheral muscular performance at a distance from a stay in intensive care unit

  • the design of a personalized interventional study in order to improve the functional autonomy

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Mobility, Functional Autonomy and Respiratory Function After Prolonged Stay in Intensive Care Unit
Anticipated Study Start Date :
Jan 1, 2022
Anticipated Primary Completion Date :
Apr 1, 2024
Anticipated Study Completion Date :
Jul 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: blood samples, muscular biopsy, and quality of life

quality of life, blood samples, quadriceps biopsy in intensive care unit (before and after the ICU hospitalization and one at M6

Other: blood sample and muscular biopsy
blood sample and muscular biopsy

Outcome Measures

Primary Outcome Measures

  1. Assessment of the functional autonomy of patient [6 months]

    The functional autonomy will be assessed by The Functional Independence Measure test (FIM score) 6 months after ICU

Secondary Outcome Measures

  1. Number of patient survival [6 months]

    Number of alive patient 180 days after stay in intensive care unit

  2. Performance of peripheral and respiratory muscles [6 months]

    Assessment of the patient deambulation assessed by a walking test

  3. metabolic stress testing [6 months]

    Assessment of the metabolic stress testing

  4. Description of the Characterization of satellite cells responsible for muscle regeneration [up to 6 months]

    The aim is only to understand and describe the Characterization of satellite cells responsible for muscle regeneration ( PAX -7).

  5. Description of the Biochemical features of the peripheral muscles [up to 6 months]

    Global physiological description of the Biochemical features of the peripheral muscles : proteolysis / proteosynthesis balance, mitochondrial fusion / fission markers, autophagy, mitophagy)

  6. Assessment of the patient Quality of life [up to 6 months]

    Quality of life assessed by the validated test EQ5D

  7. Assessment of the post ICU medical care and social environement [up to 6 months]

    Assessed by the validatedtest : Social Provisions Scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • mechanical ventilation for at least 72 hours and extra-respiratory organ failure
Exclusion Criteria:
  • neurological or psychiatric deficit preventing the performance of assessment tests,

  • chronic ventilation on tracheotomy, bedridden patient or moribund

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University Hospital, Montpellier

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Montpellier
ClinicalTrials.gov Identifier:
NCT04319822
Other Study ID Numbers:
  • RECHMPL18_0465_7732
First Posted:
Mar 24, 2020
Last Update Posted:
Dec 29, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Montpellier

Study Results

No Results Posted as of Dec 29, 2021